NEW YORK (Reuters Health) – Methotrexate and azathioprine are similarly effective as systemic treatments for severe atopic dermatitis in adults, according to the results of a head-to-head trial…
NEW YORK (Reuters Health) – Based on the results of a double-blind comparative trial, an extract of a plant commonly known as butterbur is an effective treatment for…
NEW YORK (Reuters Health) – A Danish observational study provides no evidence that use of angiotensin receptor blockers (ARBs) is associated with an increased risk of incident cancer…
NEW YORK (Reuters Health) – A just-published clinical report from the American Academy of Pediatrics (AAP) provides comprehensive guidance on the care of people with fragile X syndrome…
NEW YORK (Reuters Health) – Insulin resistance substantially curbs the chances of a sustained viral response following standard treatment for chronic hepatitis C virus (HCV) infection, according to…
NEW YORK (Reuters Health) – Perinatal transmission of hepatitis B virus from highly viremic mothers to their offspring is substantially reduced with telbivudine therapy during pregnancy, without any…
NEW YORK (Reuters Health) – Results of an integrated analysis of pooled data from two clinical trials confirm that the recombinant peptide ecallantide (Kalbitor; Dyax Corp) reduces symptoms…
NEW YORK (Reuters Health) – Long-term results confirm that use of neoadjuvant chemotherapy in treating muscle-invasive cancer of the bladder confers a significant survival advantage, an international collaborative…
NEW YORK (Reuters Health) – Ceftazidime and amikacin delivered by nebulizer is as effective as intravenous administration in treating ventilator-associated pneumonia (VAP) caused by Pseudomonas aeruginosa, and is…
NEW YORK (Reuters Health) – Contrary to previous findings, patients with advanced cancer do not have significantly improved survival when they are treated with a low-molecular-weight heparin, European…
